Table 2. Patients’ characteristics
From: COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
Characteristics | Survivors (n=91) | Non-survivors (n=89) | P value | ||
|---|---|---|---|---|---|
No. | % | No. | % | ||
Age | 0.000* | ||||
<60 | 46 | 25.56 | 19 | 10.56 | |
≥60 | 45 | 25.00 | 70 | 38.89 | |
Sex | 0.335 | ||||
Male | 54 | 30.00 | 59 | 32.78 | |
Female | 37 | 20.56 | 30 | 16.67 | |
Cancer history | 0.003* | ||||
Yes | 0 | 8 | 4.44 | ||
No | 91 | 50.56 | 81 | 45.00 | |
Diabetes history | 0.156 | ||||
Yes | 13 | 7.22 | 20 | 11.11 | |
No | 78 | 43.33 | 69 | 38.33 | |
VTE history | 0.321 | ||||
Yes | 1 | 0.56 | 0 | ||
No | 90 | 50.00 | 89 | 49.44 | |